Following up on the last post, Dr. Mike Lawlor sent me this in an email:
"Audentes
Therapeutics officially announced the dosing of the first patient for the
X-linked myotubular myopathy treatment trial that we’ve been working on over
the past few years. We’ve been very involved in the translation from dogs
to humans, and will be doing the human pathology work for the trial.
Here’s a link to that press release."
Subscribe to:
Post Comments (Atom)
-
Shannon Curran, MS with her dissection Shannon Curran, a graduate student in the Modern Human Anatomy Program at the University of Co... -
Neuropathology Blog has run its course. It's been a fantastic experience authoring this blog over many years. The blog has been a source...
No comments:
Post a Comment